MENU
+Compare
CDT
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$2.31
Change
-$0.18 (-7.23%)
Capitalization
3.12M

CDT CDT Equity Inc. Forecast, Technical & Fundamental Analysis

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients... Show more

CDT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CDT with price predictions
Nov 12, 2025

CDT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 10, 2025

CDT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 28 cases where CDT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for CDT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 38 cases where CDT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CDT just turned positive on October 23, 2025. Looking at past instances where CDT's MACD turned positive, the stock continued to rise in of 31 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CDT advanced for three days, in of 95 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CDT as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CDT entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.885) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.723).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CDT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4995 Murphy Canyon Road
Phone
+1 760 471-8536
Employees
N/A
Web
https://www.conduitpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHIM2.520.30
+13.51%
Shimmick Corp
PGNY24.420.35
+1.45%
Progyny
BXC55.61-2.12
-3.67%
BlueLinx Holdings
EVR306.61-14.55
-4.53%
Evercore
SHPH2.31-0.20
-7.97%
Shuttle Pharmaceuticals Holdings Inc

CDT and Stocks

Correlation & Price change

A.I.dvisor tells us that CDT and CMND have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CDT and CMND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDT
1D Price
Change %
CDT100%
-6.39%
CMND - CDT
32%
Poorly correlated
-32.32%
NRSN - CDT
23%
Poorly correlated
-2.43%
HOTH - CDT
23%
Poorly correlated
N/A
ZIVO - CDT
22%
Poorly correlated
N/A
VTVT - CDT
22%
Poorly correlated
+6.53%
More